Domov › Nemalicelični pljučni rak › Texas › League City
Klinične študije za Nemalicelični pljučni rak v League City, TX
15 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v League City in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Vključevanje udeležencevFaza 3
- University Of Texas Medical Branch At Galveston, Galveston · 23 mi stran
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 3
- The University of Texas, MD Anderson Cancer Center - League City, League City
- Texas Oncology - Gulf Coast, Webster · 3 mi stran
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Kelsey-Seybold Clinic - Bay Area Campus Building A, Webster · 3 mi stran
- Kelsey-Seybold Clinic - Bay Area Campus Building B, Webster · 3 mi stran
- Kelsey-Seybold Clinic - Bay Area Campus Building C, Webster · 3 mi stran
- in še 1
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- Texas Oncology-Gulf Coast, Webster · 3 mi stran
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Research Site, Galveston · 23 mi stran
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 2
- University of Texas Medical Branch, Galveston · 23 mi stran
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Vključevanje udeležencevFaza 3
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Vključevanje udeležencevFaza 3
- Local Institution - 0692, Galveston · 23 mi stran
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Vključevanje udeležencevFaza 3
- Clinical Study Site, Webster · 3 mi stran
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- USO - Texas Oncology, Webster · 3 mi stran
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Research Site, Webster · 3 mi stran
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Tranquil Clinical Research, Webster · 3 mi stran
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- MD Anderson League City, League City
PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Vključevanje udeležencev
- University of Texas Medical Branch at Galveston, Galveston · 23 mi stran
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY121 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH57 študij
- Washington, DC55 študij
Druge študije v League City
- Rak dojke12 študij
- Metastatski rak7 študij
- Ulcerativni kolitis6 študij
- Rak pljuč6 študij
- Kolorektalni rak6 študij
- Rak (vse vrste)5 študij
- Rak jajčnikov5 študij
- Možganska kap5 študij
- Rak mehurja4 študij
- Ploščatocelični karcinom glave in vratu4 študij
- Rak prostate4 študij
- Stanja po COVID-19 (dolgotrajni COVID)3 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.